Jump to main content
Jump to site search

Issue 46, 2014
Previous Article Next Article

Dextran coated bismuth–iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging

Author affiliations

Abstract

Bismuth nanoparticles have been proposed as a novel CT contrast agent, however few syntheses of biocompatible bismuth nanoparticles have been achieved. We herein report the synthesis of composite bismuth–iron oxide nanoparticles (BION) that are based on a clinically approved, dextran-coated iron oxide formulation; the particles have the advantage of acting as contrast agents for both CT and MRI. BION were synthesized and characterized using various analytical methods. BION CT phantom images revealed that the X-ray attenuation of the different formulations was dependent upon the amount of bismuth present in the nanoparticle, while T2-weighted MRI contrast decreased with increasing bismuth content. No cytotoxicity was observed in Hep G2 and BJ5ta cells after 24 hours incubation with BION. The above properties, as well as the yield of synthesis and bismuth inclusion efficiency, led us to select the Bi-30 formulation for in vivo experiments, performed in mice using a micro-CT and a 9.4 T MRI system. X-ray contrast was observed in the heart and blood vessels over a 2 hour period, indicating that Bi-30 has a prolonged circulation half-life. Considerable signal loss in T2-weighted MR images was observed in the liver compared to pre-injection scans. Evaluation of the biodistribution of Bi-30 revealed that bismuth is excreted via the urine, with significant concentrations found in the kidneys and urine. In vitro experiments confirmed the degradability of Bi-30. In summary, dextran coated BION are biocompatible, biodegradable, possess strong X-ray attenuation properties and also can be used as T2-weighted MR contrast agents.

Graphical abstract: Dextran coated bismuth–iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging

Back to tab navigation

Supplementary files

Publication details

The article was received on 15 Jul 2014, accepted on 02 Oct 2014 and first published on 02 Oct 2014


Article type: Paper
DOI: 10.1039/C4TB01159G
Citation: J. Mater. Chem. B, 2014,2, 8239-8248
  •   Request permissions

    Dextran coated bismuth–iron oxide nanohybrid contrast agents for computed tomography and magnetic resonance imaging

    P. C. Naha, A. Al Zaki, E. Hecht, M. Chorny, P. Chhour, E. Blankemeyer, D. M. Yates, W. R. T. Witschey, H. I. Litt, A. Tsourkas and D. P. Cormode, J. Mater. Chem. B, 2014, 2, 8239
    DOI: 10.1039/C4TB01159G

Search articles by author

Spotlight

Advertisements